Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Anticancer Activity of Alectinib through Hydroxypropyl-β-Cyclodextrin Complexation: In Vitro Evaluation on A549 Lung Cancer Cells.
Journal: Drug research
Published: December 29, 2025
Development and Evaluation of a Cost-Effective, Carbon-Based, Extended-Release Febuxostat Tablet.
Journal: Molecules (Basel, Switzerland)
Published: August 23, 2024
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 30, 2024
Anti-diabetic effect of cotreatment with resveratrol and pioglitazone in diabetic rats.
Journal: European review for medical and pharmacological sciences
Published: January 17, 2023
Esomeprazole and apixaban pharmacokinetic interactions in healthy rats.
Journal: Heliyon
Published: March 24, 2022
Showing 1-6 of 6
Last Updated: 09/26/2026